AI eye on the womb: new MRI model aims to spot hidden cancer
NCT ID NCT07269535
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will check if an artificial intelligence (AI) model can accurately tell the difference between common, non-cancerous uterine fibroids and a rare but serious cancer called uterine sarcoma using MRI scans. Researchers will enroll 500 women who are scheduled for surgery or long-term follow-up. The goal is to see if the AI tool works well in real-world hospital settings to help doctors make faster, more accurate diagnoses and guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AI (ARTIFICIAL INTELLIGENCE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- MRI scans may help prevent intestinal damage in Crohn's disease
- Fine-Tuning MRI scanners to sharpen the picture of the brain
- AI could slash MRI scan times without sacrificing quality
- New chemo cocktail aims to fight childhood germ cell tumors that return
- AI could help doctors diagnose lung cancer faster during a bronchoscopy
- New study uses advanced scans to map brain inflammation over time